Patents by Inventor Roksan Libinaki

Roksan Libinaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210321641
    Abstract: The present invention relates to a method for improving performance parameters of an animal comprising administering to the animal a mixture of a mono-tocopheryl phosphate and a di-tocopheryl phosphate, wherein the di-tocopheryl phosphate is in a proportion of at least 10% by weight of the tocopheryl phosphate mixture.
    Type: Application
    Filed: June 21, 2021
    Publication date: October 21, 2021
    Inventor: Roksan Libinaki
  • Publication number: 20200060311
    Abstract: The present invention relates to a method for improving performance parameters of an animal comprising administering to the animal a mixture of a mono-tocopheryl phosphate and a di-tocopheryl phosphate, wherein the di-tocopheryl phosphate is in a proportion of at least 10% by weight of the tocopheryl phosphate mixture.
    Type: Application
    Filed: December 11, 2017
    Publication date: February 27, 2020
    Inventor: Roksan Libinaki
  • Publication number: 20190298834
    Abstract: The present invention relates to a carrier composition comprising a phosphate compound of an electron transfer agent and a polar aprotic solvent. Biologically active compounds formulated with the carrier composition have been shown to have improved properties.
    Type: Application
    Filed: June 11, 2019
    Publication date: October 3, 2019
    Inventors: Paul David Gavin, Mahmoud El-Tamimy, Roksan Libinaki, Mohammad Reza Mozafari
  • Patent number: 10188670
    Abstract: Compositions and formulations comprising a non-neutralized tocol phosphate and a vitamin A compound, which are suitable for the treatment of inflammation and/or infection in breast or udder tissue, more particularly in a mammary gland, reducing the somatic cell count in a lactating subject and supplementing vitamin E levels in a subject.
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: January 29, 2019
    Assignee: Phosphagenics Limited
    Inventor: Roksan Libinaki
  • Patent number: 10071030
    Abstract: The present invention relates to a carrier for the delivery of a nutraceutical or cosmeceutical active comprising non-neutralized tocopheryl phosphate and a hydrophobic vehicle. The present invention also relates to a formulation comprising the carrier and a nutraceutical or cosmeceutical active.
    Type: Grant
    Filed: February 4, 2011
    Date of Patent: September 11, 2018
    Assignee: Phosphagenics Limited
    Inventor: Roksan Libinaki
  • Publication number: 20170112863
    Abstract: Compositions and formulations comprising a non-neutralised tocol phosphate and a vitamin A compound, which are suitable for the treatment of inflammation and/or infection in breast or udder tissue, more particularly in a mammary gland, reducing the somatic cell count in a lactating subject and supplementing vitamin E levels in a subject.
    Type: Application
    Filed: January 6, 2017
    Publication date: April 27, 2017
    Inventors: Roksan Libinaki, Robert Lee Neely
  • Patent number: 9561243
    Abstract: Compositions and formulations comprising a non-neutralized tocol phosphate and a vitamin A compound, which are suitable for the treatment of inflammation and/or infection in breast or udder tissue, more particularly in a mammary gland, reducing the somatic cell count in a lactating subject and supplementing vitamin E levels in a subject.
    Type: Grant
    Filed: March 2, 2012
    Date of Patent: February 7, 2017
    Assignee: Phosphagenics Limited
    Inventor: Roksan Libinaki
  • Publication number: 20160375136
    Abstract: The present invention relates to a carrier composition comprising a phosphate compound of an electron transfer agent and a polar aprotic solvent. Biologically active compounds formulated with the carrier composition have been shown to have improved properties.
    Type: Application
    Filed: September 9, 2016
    Publication date: December 29, 2016
    Inventors: Paul David Gavin, Mahmoud El-Tamimy, Roksan Libinaki, Mohammad Reza Mozafari
  • Publication number: 20140255509
    Abstract: Compositions and formulations comprising a non-neutralised tocol phosphate and a vitamin A compound, which are suitable for the treatment of inflammation and/or infection in breast or udder tissue, more particularly in a mammary gland, reducing the somatic cell count in a lactating subject and supplementing vitamin E levels in a subject.
    Type: Application
    Filed: March 2, 2012
    Publication date: September 11, 2014
    Applicant: PHOSPHAGENICS LIMITED
    Inventors: Roksan Libinaki, Robert Lee Neely
  • Publication number: 20120321604
    Abstract: The present invention relates to a carrier for the delivery of a nutraceutical or cosmeceutical active comprising non-neutralised tocopheryl phosphate and a hydrophobic vehicle. The present invention also relates to a formulation comprising the carrier and a nutraceutical or cosmeceutical active.
    Type: Application
    Filed: February 4, 2011
    Publication date: December 20, 2012
    Inventor: Roksan Libinaki
  • Publication number: 20120283233
    Abstract: The present invention relates to a carrier composition comprising a phosphate compound of an electron transfer agent and a polar aprotic solvent. Biologically active compounds formulated with the carrier composition have been shown to have improved properties.
    Type: Application
    Filed: February 4, 2011
    Publication date: November 8, 2012
    Inventors: Paul David Gavin, Mahmoud El-Tamimy, Roksan Libinaki, Mohammad Reza Mozafari
  • Publication number: 20090239827
    Abstract: There is provided a therapy for lowering the blood levels of a lipid selected from the group comprising LDL cholesterol, triglycerides, overall cholesterol and mixtures thereof, the therapy comprising the step of administering an effective amount of one or more phosphate derivatives of one or more electron transfer agents.
    Type: Application
    Filed: January 6, 2006
    Publication date: September 24, 2009
    Inventors: Esra Ogru, Roksan Libinaki, Simon Michael West
  • Publication number: 20090005348
    Abstract: A method of modulating one or more immuno-regulatory cytokines, such as pro-inflammatory and/or anti-inflammatory cytokines, comprising administering to a subject a therapeutically effective amount of one or more phosphate derivatives of one or more hydroxy chromans, or complexes thereof.
    Type: Application
    Filed: December 22, 2006
    Publication date: January 1, 2009
    Applicant: VITAL HEALTH SCIENCES PTY LTD
    Inventors: Esra Ogru, Roksan Libinaki, Robert Gianello